MedCity News April 26, 2024
Peter Bannister and Alan Thomas Kohler

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments.

Pharmacogenomics (PGx), the study of how genetic profiles impact an individual’s responses to medication, has already begun to help healthcare providers (HCPs) optimize care through its capacity to preemptively enhance drug efficacy, minimize adverse side effects, and improve patient experiences. This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments, one that serves patients by supporting clinicians to better predict therapeutic responses and more accurately optimize drug dosages.

But, with data-driven solutions come data-driven challenges, not the least of which is the size and complexity of the datasets...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Primary care, Provider, Technology
Related Articles:
5 objectives for achieving high-quality primary care at the state level
70% of Americans want primary care providers to address mental health
Shoulder Pain Pointers for Primary Care
California aims for insurers to spend 15% on primary care by 2034: 8 notes
Most Americans want primary care providers to address mental health, survey finds

Share This Article